ADAPTDX

Welcome to the Brand page for “ADAPTDX”, which is offered here for Immunosequencing-based assay kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, for detection of cancer, autoimmune disease and infection; medical diagnostic assay kits comprised of medical diagnostic reagents and assays for detecting cancer, autoimmune disease and infection; the aforementioned goods not in the field of or for use in the field of ocular diagnostics or treatment, including ophthalmology and optometry, and not for use in providing sales, marketing, or consulting services, including direct to consumer sales, direct to consumer marketing, and providing consulting services, in the field of ocular diagnostics or treatment;adapted;providing medical diagnostic and prognostic testing for cancer, autoimmune disease and infection, and the analysis, evaluation, and reporting of those test results to help healthcare professionals determine a patient's clinical diagnosis, the effectiveness of patient treatments, and to revise future treatments accordingly; providing medical diagnostic and prognostic testing services; medical services; consulting services in the field of medical diagnostic testing; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; the aforementioned services not in the field of or for use in the field of ocular diagnostics or treatment, including ophthalmology and optometry, and not for use in providing sales, marketing, or consulting services, including direct to consumer sales, direct to consumer marketing, and providing consulting services, in the field of ocular diagnostics or treatment;medical laboratory services; the aforementioned services not in the field of or for use in the field of ocular diagnostics or treatment, including ophthalmology and optometry, and not for use in providing sales, marketing, or consulting services, including direct to consumer sales, direct to consumer marketing, and providing consulting services, in the field of ocular diagnostics or treatment;.

Its status is currently believed to be active. Its class is unavailable. “ADAPTDX” is believed to be currently owned by “ADAPTIVE BIOTECHNOLOGIES CORPORATION”.